Vistagen Announces Completion of Last Patient, Last Visit in Phase 1 Clinical Trial of Itruvone (PH10), an Investigational Pherine Nasal Spray for Major Depressive Disorder - Yahoo Finance
Submitted by Anonymous (not verified) on Wed, 03/08/2023 - 13:30
